Nationwide trends, hospital volume, and drivers of survey-weighted 30-day unplanned readmission after pancreatic resection (NRD 2016–2022).
Abstract
e16341 Background: National, survey-weighted benchmarking of 30-day unplanned readmission after pancreatic resection and its relationship with hospital volume remains limited across recent years. Methods: Using NRD 2016–2022, we identified each patient’s first pancreatic resection index admission per calendar year (ICD-10-PCS partial/total resection codes), restricted to 30-day readmission–eligible admissions. Hospital annual resection volume was categorized into year-specific quartiles. We estimated survey-weighted readmission rates and fit survey-weighted logistic regression (weights, hospital clustering, and stratification). Results: Among 28,265 eligible index resections, 2,859 had an observed 30-day unplanned readmission (crude 10.1%). Survey-weighted readmission declined from 10.1% in 2016 to 8.2% in 2022 and was lower in high-volume hospitals (Table 1). In adjusted models, Q4 vs Q1 volume was associated with lower odds of readmission, while extreme APR-DRG severity of illness was associated with higher odds (Table 1). The most common readmission diagnosis categories were Other (50.6%), Postoperative complication (29.4%), and Sepsis/Septicemia (10.5%). Conclusions: Survey-weighted national readmission after pancreatic resection remained near 8–11% and was consistently lower at higher-volume hospitals, supporting targeted transitional-care interventions and dissemination of high-volume program practices. Key survey-weighted estimates (NRD 2016–2022). Domain Comparison / Year Estimate (95% CI) 30-day unplanned readmission rate 2016 0.101 (0.090–0.113) 30-day unplanned readmission rate 2022 0.082 (0.072–0.093) Rate by hospital volume quartile Q1 (lowest) 0.143 (0.114–0.173) Rate by hospital volume quartile Q4 (highest) 0.094 (0.089–0.099) Adjusted odds (survey-weighted logistic) Q4 vs Q1 OR 0.69 (0.54–0.89) Adjusted odds (survey-weighted logistic) Elective vs non-elective OR 0.80 (0.70–0.93) Adjusted odds (survey-weighted logistic) APR-DRG severity extreme vs minor OR 1.72 (1.29–2.29)
Article Details
Journal Info
Journal of Clinical Oncology
Lippincott Williams & Wilkins
Authors (5)
Woo Joo Lee
1AdventHealth Sebring, Internal Medicine Residency, Sebring, United States
Sumbal Aziz
1AdventHealth Sebring, Internal Medicine Residency, Sebring, United States
Robin Park
Muhammad Sohaib Asghar
Thomas Shimshak
Adventhealth Sebring, Sebring, Florida, United States